Results 131 to 140 of about 78,612 (185)

Trem2 Agonist Reprograms Foamy Macrophages to Promote Atherosclerotic Plaque Stability-Brief Report. [PDF]

Arterioscler Thromb Vasc Biol
Patterson MT, Xu Y, Hillman H, Osinski V, Schrank PR, Kennedy AE, Barrow F, Zhu A, Tollison S, Shekhar S, Stromnes IM, Tassi I, Wu D, Revelo XS, Binstadt BA, Williams JW.   +15 more
europepmc   +1 more source

Integrating genomic profiling to clinical data: assessing the impact of CD147 expression on plaque stability. [PDF]

Front Cardiovasc Med
Chen Y, Lu S, Ren Y, Fan J, Bao CP, Zhang X, Shi YK, Wang Y, Yang LX.   +8 more
europepmc   +1 more source

Urolithin A promotes atherosclerotic plaque stability by limiting inflammation and hypercholesteremia in Apolipoprotein E-deficient mice. [PDF]

Acta Pharmacol Sin
Xu MY, Xu JJ, Kang LJ, Liu ZH, Su MM, Zhao WQ, Wang ZH, Sun L, Xiao JB, Evans PC, Tian XY, Wang L, Huang Y, Liang XM, Weng JP, Xu SW.   +15 more
europepmc   +1 more source

Interleukin-6 and thyroid-stimulating hormone index predict plaque stability in carotid artery stenosis: analyses by lasso-logistic regression. [PDF]

Front Cardiovasc Med
Zhigao L, Jiabo Q, Lei Z, Tong Q.
europepmc   +1 more source

YKL40 potentially via activating the P38 pathway in decreasing atherosclerotic plaque stability. [PDF]

Chin Med J (Engl)
Wang C, Liu Y, Huan W, Wu J, Jin J, Zou S, Chen Y, Qu L.   +7 more
europepmc   +1 more source

DFMG decreases angiogenesis to uphold plaque stability by inhibiting the TLR4/VEGF pathway in mice. [PDF]

PLoS One
Bai P, Xiang X, Kang J, Xiang X, Jiang J, Fu X, Zhang Y, Li L.   +7 more
europepmc   +1 more source

N^ε-carboxyethyl-lysin influences atherosclerotic plaque stability through ZKSCAN3 acetylation-regulated macrophage autophagy via the RAGE/LKB1/AMPK1/SIRT1 pathway. [PDF]

Cardiovasc Diabetol
Liu Z, Liu J, Wang X, Zhang Y, Ma Y, Guan G, Yuwen Y, He N, Liu H, Yu X, Ma S, Wang J, Zhang J, Zhu L, Zhang Y.   +14 more
europepmc   +1 more source

Early and short-term use of proprotein convertase anti-subtilisin-kexin type 9 inhibitors on coronary plaque stability in acute coronary syndrome. [PDF]

Eur Heart J Open
Uehara H, Kajiya T, Abe M, Nakata M, Hosogi S, Ueda S.   +5 more
europepmc   +1 more source

Treatment of advanced atherosclerotic mice with ABT-263 reduced indices of plaque stability and increased mortality. [PDF]

JCI Insight
Karnewar S, Karnewar V, Shankman LS, Owens GK.   +3 more
europepmc   +1 more source

miR-449a disturbs atherosclerotic plaque stability in streptozotocin and high-fat diet-induced diabetic mice by targeting CEACAM1. [PDF]

Diabetol Metab Syndr
Yu J, Liu H, Chen Y, Wang L, Chen P, Zhao Y, Ou C, Chen W, Hu J, Wang Y, Wang Y.   +10 more
europepmc   +1 more source